Business Wire

CRAYON

Share
Crayon Expands Strategic Partnership With Workplace From Facebook

Crayon , a global leader in digital transformation, today announced it is expanding its partnership with Workplace from Facebook to change the way organizations communicate and get work done. Crayon has offered Workplace , a business collaboration tool, in the Nordics since 2018 and this new agreement will expand the partnership into 20 more countries over the next year.

Crayon has seen an increase in the need for collaborative tools as companies around the world shifted to a new approach to work, connecting a more remote and distributed workforce. The expanded partnership means Crayon and Workplace will help organizations work closer together, break down communication silos and enable stronger company culture, especially with remote and frontline workers by providing a unified system of engagement and collaboration.

“This partnership means we can help more companies to connect on one platform so that everyone feels like they have a voice in the organization,” said Crayon co-founder Rune Syversen. “We understand the challenge of the connected company has nothing to do with technology, it has to do with changing the culture toward open collaboration. Our Workplace program is about just that – helping our customers to leverage the benefits of the Workplace platform emphasizing cultural changes. Since we started this partnership, we’ve observed Workplace becoming our fastest growing tech partner, particularly as the technology works well with the Microsoft IT stack. For us, along with Workplace, it’s not just another IT implementation, it is an introduction of a whole new way of communicating across the entire company.”

Crayon has helped deploy Workplace at all types of organizations, from healthcare companies to transportation organizations globally.

“Our employees have different workspaces, some are working from their office, others are working from a farm. We needed a way to communicate with everyone across the organization regardless of where or how they did their job and Workplace made that possible,” said Meylin S. Loo, Digital Communications Chief for Tine in Norway.

“Also, for us it was important to have a partner that had implemented this solution before to give us crucial guidance on best practices. Plus, we already have a long-standing successful relationship with Crayon and so we knew they were the right one to help us implement Workplace.”

Among the 20 countries that Crayon and Workplace will expand to include Norway, Denmark, Sweden, Finland, the UK, France and the US.

“We are proud to expand our partnership with Crayon, which has dozens of joint Workplace customers and has added their technical expertise to each launch to enable wall-to-wall adoption of Workplace across every employee in an organization. This deepened partnership and new growth trajectory is another important milestone on our two companies’ journeys. Right now companies around the world are trying to keep their workforces connected, engaged and keep their employees informed, and we believe that Workplace is a perfect solution for many of today’s real-world challenges,” said Julien Codorniou, VP, Workplace from Facebook.

About Crayon:

Crayon helps customers build the commercial and technical foundation for a successful digital transformation journey through a reliable services framework allowing our customers to right-size and optimize their IT estates. Headquartered in Oslo, Norway, Crayon has over 1600 employees across more than 50 locations worldwide.

Link:

ClickThru

Social Media:

https://www.facebook.com/CrayonITGroup

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release

Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release

SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f

Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press release

Through the Extreme Exchange (IX) acquisition, Megaport gains seven Internet Exchanges and access to 40+ data centres across India’s fastest-growing digital hubs. Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly thr

IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 22:10:00 CET | Press release

Extension solidifies QuantumBasel as IonQ’s Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercialization IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerston

Suzano Starts Up New Production Line, Boosting Its Fluff Pulp Capacity by 400%17.12.2025 21:50:00 CET | Press release

A R$490 million investment expands the supply of raw material used in the production of absorbent items Suzano, the world’s largest pulp producer, has commenced operations this week at its new fluff pulp production line located in its Limeira unit in Brazil’s São Paulo state. This R$490 million investment increases Suzano’s total fluff pulp production capacity by more than 400%, from 100,000 to 440,000 tonnes per year. The project involved converting the existing pulp line at the Limeira unit into a flexible machine, capable of producing both Eucafluff® and market pulp. Eucafluff® is used in the production of absorbent and personal hygiene products, such as baby and adult diapers, sanitary pads and pet pads. Then market pulp is supplied for making products including toilet paper, printing and writing papers, and paper packaging. Launched in 2015, Eucafluff® is the world’s first fluff pulp made from eucalyptus, delivering unique advantages like enhanced softness and flexibility, which t

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye